• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Complaint, Ill-Defined (2331); Cognitive Changes (2551)
Event Date 07/20/2020
Event Type  Injury  
Manufacturer Narrative
Please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Testo aa, garnaat sl, corse ak, et al.A case of non-affective psychosis followed by extended response to non-stimulation in deep brain stimulation for obsessive-compulsive disorder.Brain stimul.2020;13(5):1317-1319.10.1016/j.Brs.2020.06.019.The study sought to investigate effectiveness of dbs as a treatment for intractable ocd, as preliminary data had shown promising therapeutic effects.Reported events: approximately 18 months after implantation, the patient presented with an acute onset of psychotic symptoms shortly after dbs amplitude was increased.At the following visit dbs voltage was reduced, but psychotic symptoms persisted.The patient described ideas of reference, magical thinking unrelated to any previous ocd symptoms (e.G., talking to trees), and other delusional beliefs.There was no accompanying grandiosity, euphoria, pleasure-seeking, or change in sleep suggesting hypomania.His functioning worsened in tandem.An antipsychotic was started (risperidone 2mg/day).The patient's condition improved with stimulation turned off and an increased dose in medication.The patient's stimulation was turned off for 2 years, and ocd symptoms remains in control.After two years the patient's ocd symptoms retuned so stimulation was turned back and the patient's condition improved.It was not possible to ascertain specific device information from the article or to match the reported event with any previously reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE NEUROSTIMULATOR
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
david gustafson
7000 central avenue ne rcw215
minneapolis, MN 55432
7635149628
MDR Report Key10531955
MDR Text Key206968373
Report Number2182207-2020-00876
Device Sequence Number1
Product Code MFR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H050003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/20/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age20 YR
-
-